Literature DB >> 19027813

Eczema vaccinatum resulting from the transmission of vaccinia virus from a smallpox vaccinee: an investigation of potential fomites in the home environment.

Edith Lederman1, Roque Miramontes, John Openshaw, Victoria A Olson, Kevin L Karem, John Marcinak, Rodrigo Panares, Wayne Staggs, Donna Allen, Stephen G Weber, Surabhi Vora, Susan I Gerber, Christine M Hughes, Russell Regnery, Limone Collins, Pamela S Diaz, Mary G Reynolds, Inger Damon.   

Abstract

On March 3, 2007, a 2-year-old boy was hospitalized with eczema vaccinatum. His two siblings, one with eczema, were subsequently removed from the home. Swabs of household items obtained on March 13th were analyzed for orthopoxvirus DNA signatures with real-time PCR. Virus culture was attempted on positive specimens. Eight of 25 household samples were positive by PCR for orthopoxvirus; of these, three yielded viable vaccinia virus in culture. Both siblings were found to have serologic evidence of orthopoxvirus exposure. These findings have implications for smallpox preparedness, especially in situations where some household members are not candidates for vaccination.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19027813     DOI: 10.1016/j.vaccine.2008.11.019

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

1.  Transport of Bacillus thuringiensis var. kurstaki via fomites.

Authors:  Sheila Van Cuyk; Lee Ann B Veal; Beverley Simpson; Kristin M Omberg
Journal:  Biosecur Bioterror       Date:  2011-09

2.  Comparison of surface sampling methods for virus recovery from fomites.

Authors:  Timothy R Julian; Francisco J Tamayo; James O Leckie; Alexandria B Boehm
Journal:  Appl Environ Microbiol       Date:  2011-08-05       Impact factor: 4.792

3.  Reservoir targeted vaccine for lyme borreliosis induces a yearlong, neutralizing antibody response to OspA in white-footed mice.

Authors:  Luciana Meirelles Richer; Miguel Aroso; Tania Contente-Cuomo; Larisa Ivanova; Maria Gomes-Solecki
Journal:  Clin Vaccine Immunol       Date:  2011-09-14

4.  Deletion of the A35 gene from Modified Vaccinia Virus Ankara increases immunogenicity and isotype switching.

Authors:  Kristina E Rehm; Rachel L Roper
Journal:  Vaccine       Date:  2011-02-23       Impact factor: 3.641

5.  Vaccinia virus A35R inhibits MHC class II antigen presentation.

Authors:  Kristina E Rehm; Ramsey F Connor; Gwendolyn J B Jones; Kenneth Yimbu; Rachel L Roper
Journal:  Virology       Date:  2009-12-02       Impact factor: 3.616

6.  Low-resolution structure of vaccinia virus DNA replication machinery.

Authors:  Céleste Sèle; Frank Gabel; Irina Gutsche; Ivan Ivanov; Wim P Burmeister; Frédéric Iseni; Nicolas Tarbouriech
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

7.  Educational Approach to Prevent the Burden of Vaccinia Virus Infections in a Bovine Vaccinia Endemic Area in Brazil.

Authors:  Galileu Barbosa Costa; Jaqueline Silva de Oliveira; Michael B Townsend; William C Carson; Iara Apolinário Borges; Andrea M McCollum; Erna Geessien Kroon; Panayampalli Subbian Satheshkumar; Mary G Reynolds; Yoshinori J Nakazawa; Giliane de Souza Trindade
Journal:  Pathogens       Date:  2021-04-23

8.  ST-246 inhibits in vivo poxvirus dissemination, virus shedding, and systemic disease manifestation.

Authors:  Aklile Berhanu; David S King; Stacie Mosier; Robert Jordan; Kevin F Jones; Dennis E Hruby; Douglas W Grosenbach
Journal:  Antimicrob Agents Chemother       Date:  2009-09-14       Impact factor: 5.938

9.  Safety and biodistribution of a double-deleted oncolytic vaccinia virus encoding CD40 ligand in laboratory Beagles.

Authors:  Karoliina Autio; Anna Knuuttila; Anja Kipar; Sari Pesonen; Kilian Guse; Suvi Parviainen; Minna Rajamäki; Outi Laitinen-Vapaavuori; Markus Vähä-Koskela; Anna Kanerva; Akseli Hemminki
Journal:  Mol Ther Oncolytics       Date:  2014-12-10       Impact factor: 7.200

10.  Alternative Routes of Zoonotic Vaccinia Virus Transmission, Brazil.

Authors:  Galileu B Costa; Iara A Borges; Pedro A Alves; Júlia B Miranda; Ana Paula M F Luiz; Paulo C P Ferreira; Jônatas S Abrahão; Elizabeth C Moreno; Erna G Kroon; Giliane de Souza Trindade
Journal:  Emerg Infect Dis       Date:  2015-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.